These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5114388)

  • 1. Schizophrenics: the efficacy of phenothiazines.
    McNamee HB
    Am J Psychiatry; 1971 Nov; 128(5):657. PubMed ID: 5114388
    [No Abstract]   [Full Text] [Related]  

  • 2. A follow-up study of intensively treated chronic schizophrenic patients.
    Messier M; Finnerty R; Botvin CS; Grinspoon L
    Am J Psychiatry; 1969 Feb; 125(8):1123-7. PubMed ID: 5794854
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics.
    Keskiner A; Itil TM; Todt N
    Psychosomatics; 1970; 11(2):120-6. PubMed ID: 4394278
    [No Abstract]   [Full Text] [Related]  

  • 4. Group vs individual psychotherapy with schizophrenics. A controlled outcome study.
    O'Brien CP; Hamm KB; Ray BA; Pierce JF; Luborsky L; Mintz J
    Arch Gen Psychiatry; 1972 Oct; 27(4):474-8. PubMed ID: 4342116
    [No Abstract]   [Full Text] [Related]  

  • 5. The aftercare of schizophrenics: an evaluation of group and individual approaches.
    Levene HI; Patterson V; Murphey BG; Overbeck AL; Veach TL
    Psychiatr Q; 1970; 44(2):296-304. PubMed ID: 4318915
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of LSD and ditran in the treatment of therapy resistant schizophrenics (symptom provocation approach).
    Itil TM; Keskiner S; Holden JM
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:93-103. PubMed ID: 4388281
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical differences among phenothiazines in schizophrenics. Introduction: specific indications for antipsychotics: elusive end of the rainbow.
    Hollister LE
    Adv Biochem Psychopharmacol; 1974; 9(0):667-73. PubMed ID: 4151921
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A; Güclü B; Kulkarni AS
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychotherapy and pharmacotherapy in chronic schizophrenia.
    Grinspoon L; Ewalt JR; Shader R
    Am J Psychiatry; 1968 Jun; 124(12):1645-52. PubMed ID: 5650757
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenothiazine effects in good premorbid schizophrenics divided into paranoid-nonparanoid status.
    Judd LL; Goldstein MJ; Rodnick EH; Jackson NL
    Arch Gen Psychiatry; 1973 Aug; 29(2):207-21. PubMed ID: 4582360
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
    Freeman H; Oktem MR; Oktem N
    Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
    [No Abstract]   [Full Text] [Related]  

  • 12. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined pharmacotherapy and psychotherapy.
    Uhlenhuth EH; Lipman RS; Covi L
    J Nerv Ment Dis; 1969 Jan; 148(1):52-64. PubMed ID: 4388798
    [No Abstract]   [Full Text] [Related]  

  • 14. Performance tests in a study of phenothiazines in schizophrenia: caveats and conclusions.
    Schooler NR; Goldberg SC
    Psychopharmacologia; 1972; 24(1):81-98. PubMed ID: 5062969
    [No Abstract]   [Full Text] [Related]  

  • 15. Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.
    Gershon S; Hekimian LJ; Burdock EI; Park S; Floyd A
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):810-8. PubMed ID: 4396420
    [No Abstract]   [Full Text] [Related]  

  • 16. Prediction of response to phenothiazines in schizophrenia. A crossvalidation study.
    Goldberg SC; Frosch WA; Drossman AK; Schooler NR; Johnson GF
    Arch Gen Psychiatry; 1972 Apr; 26(4):367-73. PubMed ID: 4552130
    [No Abstract]   [Full Text] [Related]  

  • 17. The relationship between blood levels of different forms of butaperazine and clinical response.
    Simpson GM; Lament R; Cooper TB; Lee JH; Bruce RB
    J Clin Pharmacol; 1973 Jul; 13(7):288-97. PubMed ID: 4145866
    [No Abstract]   [Full Text] [Related]  

  • 18. Premorbid adjustment, phenothiazine treatment, and remission in acute schizophrenics.
    Evans JR; Rodnick EH; Goldstein MJ; Judd LL
    Arch Gen Psychiatry; 1972 Oct; 27(4):486-90. PubMed ID: 4342117
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of dosage ranges of carphenazine and trifluoperazine in elderly chronic schizophrenics.
    Bora G
    Dis Nerv Syst; 1968 Oct; 29(10):695-7. PubMed ID: 4887393
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of Tybamate in chronic schizophrenia. (Minor tranquilizers as adjunct therapy in psychosis).
    Serafetinides EA; Clark ML
    Dis Nerv Syst; 1971 Aug; 32(8):567-71. PubMed ID: 5094163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.